Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 948

1.

Proposed Definition for Oligometastatic Recurrence in Biliary Tract Cancer Based on Results of Locoregional Treatment: A Propensity-Score-Stratified Analysis.

Morino K, Seo S, Yoh T, Fukumitsu K, Ishii T, Taura K, Morita S, Kaido T, Uemoto S.

Ann Surg Oncol. 2020 Jan 14. doi: 10.1245/s10434-020-08207-0. [Epub ahead of print]

PMID:
31939034
2.

Impact of the preoperative bone mineral density on the outcomes after resection of pancreatic cancer.

Sharshar M, Kaido T, Shirai H, Okumura S, Yao S, Miyachi Y, Iwamura S, Kamo N, Yagi S, Macshut M, Uemoto S.

Surg Today. 2020 Jan 10. doi: 10.1007/s00595-019-01954-y. [Epub ahead of print]

PMID:
31925578
3.

[Kidney Auto-Transplantation for Intraoperative Right Renal Artery Injury in a Single Kidney Patient : A Case Report].

Magaribuchi T, Kobayashi T, Kamo N, Kaido T, Sakai K, Teramoto Y, Ito K, Kubota M, Takada H, Sawada A, Akamatsu S, Yamasaki T, Inoue T, Yanagita M, Uemoto S, Ogawa O.

Hinyokika Kiyo. 2019 Nov;65(11):455-458. doi: 10.14989/ActaUrolJap_65_11_455. Japanese.

PMID:
31902178
4.

Use of Nakanuma staging and cytokeratin 7 staining for diagnosing recurrent primary biliary cholangitis after living-donor liver transplantation.

Yamashiki N, Haga H, Ueda Y, Ito T, Yagi S, Kamo N, Hata K, Mori A, Kaido T, Okajima H, Uemoto S.

Hepatol Res. 2019 Dec 18. doi: 10.1111/hepr.13476. [Epub ahead of print]

PMID:
31851426
5.

Cholangiocarcinoma after flow diversion surgery for congenital biliary dilatation: A case report and review of literature.

Ataka R, Ito T, Masui T, Seo S, Ishii T, Ogiso S, Yagi S, Taura K, Uemoto S.

World J Hepatol. 2019 Nov 27;11(11):743-751. doi: 10.4254/wjh.v11.i11.743.

6.

ALPlat criterion for the resection of hepatocellular carcinoma based on a predictive model of posthepatectomy liver failure.

Yamamoto G, Taura K, Ikai I, Fujikawa T, Nishitai R, Kaihara S, Zaima M, Terajima H, Yoshimura T, Koyama Y, Tanabe K, Nishio T, Okuda Y, Ikeno Y, Yoshino K, Fukuyama K, Seo S, Hatano E, Uemoto S.

Surgery. 2020 Feb;167(2):410-416. doi: 10.1016/j.surg.2019.09.021. Epub 2019 Nov 11.

PMID:
31727326
7.

Bortezomib Against Refractory Antibody-Mediated Rejection After ABO-Incompatible Living-Donor Liver Transplantation: Dramatic Effect in Acute-Phase?

Tajima T, Hata K, Okajima H, Nishikori M, Yasuchika K, Kusakabe J, Yoshizawa A, Fukumitsu K, Anazawa T, Tanaka H, Wada S, Doi J, Takaori-Kondo A, Uemoto S.

Transplant Direct. 2019 Sep 19;5(10):e491. doi: 10.1097/TXD.0000000000000932. eCollection 2019 Oct.

8.

Reply.

Kusakabe J, Yagi S, Uemoto S.

Liver Transpl. 2019 Nov 6. doi: 10.1002/lt.25676. [Epub ahead of print] No abstract available.

PMID:
31693780
9.

Assessment and significance of sarcopenia in liver transplantation.

Nam NH, Kaido T, Uemoto S.

Clin Transplant. 2019 Dec;33(12). doi: 10.1111/ctr.13741. Epub 2019 Nov 6. Review.

PMID:
31651060
10.

A Multicenter Japanese Survey Assessing the Long-Term Outcomes of Liver Retransplantation using Living Donor Grafts.

Kuramitsu K, Fukumoto T, Egawa H, Ohdan H, Umeshita K, Uemoto S, Hibi T, Kasahara M, Yoshizumi T, Mizuta K, Shimamura T, Furukawa H.

Transplantation. 2019 Sep 13. doi: 10.1097/TP.0000000000002958. [Epub ahead of print]

PMID:
31568214
11.

Long-term impact and clinical significance of living donor liver transplantation with respect to donor liver restoration and spleen size: A prospective study.

Yoshino K, Taura K, Ikeno Y, Kimura Y, Hai Nam N, Uemoto Y, Okuda Y, Nishio T, Yamamoto G, Iwaisako K, Seo S, Kaido T, Uemoto S.

Am J Transplant. 2019 Sep 30. doi: 10.1111/ajt.15627. [Epub ahead of print]

PMID:
31566887
12.

Anatomical Pitfall in Right Posterior Sector Graft Procurement in Living Donor Liver Transplantation.

Kusakabe J, Yagi S, Okamura Y, Iida T, Ogawa E, Ito T, Hata K, Taura K, Okajima H, Kaido T, Uemoto S.

Liver Transpl. 2020 Feb;26(2):299-303. doi: 10.1002/lt.25648. Epub 2019 Nov 25. No abstract available.

PMID:
31563152
13.

A Dual Protective Effect of Intestinal Remote Ischemic Conditioning in a Rat Model of Total Hepatic Ischemia.

Czigany Z, Hata K, Lai W, Schwandt T, Yamamoto Y, Uemoto S, Tolba RH.

J Clin Med. 2019 Sep 26;8(10). pii: E1546. doi: 10.3390/jcm8101546.

14.

A clinical pilot study of Resection Process Map: A novel virtual hepatectomy software to visualize the resection process, case series.

Uchida Y, Taura K, Nakao M, Uemoto S.

Int J Surg. 2019 Nov;71:36-40. doi: 10.1016/j.ijsu.2019.09.002. Epub 2019 Sep 13.

PMID:
31525504
15.

Survey of preoperative management protocol for perihilar cholangiocarcinoma at 10 Japanese high-volume centers with a combined experience of 2,778 cases.

Chaudhary RJ, Higuchi R, Nagino M, Unno M, Ohtsuka M, Endo I, Hirano S, Uesaka K, Hasegawa K, Wakai T, Uemoto S, Yamamoto M.

J Hepatobiliary Pancreat Sci. 2019 Nov;26(11):490-502. doi: 10.1002/jhbp.668. Epub 2019 Oct 10.

PMID:
31520452
16.

Including body composition in MELD scores improves mortality prediction among patients awaiting liver transplantation.

Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Uemoto S.

Clin Nutr. 2019 Aug 21. pii: S0261-5614(19)33024-9. doi: 10.1016/j.clnu.2019.08.012. [Epub ahead of print]

PMID:
31481263
17.

Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study.

Yoh T, Cauchy F, Le Roy B, Seo S, Taura K, Hobeika C, Dokmak S, Farges O, Gelli M, Sa Cunha A, Adam R, Uemoto S, Soubrane O.

Surgery. 2019 Dec;166(6):975-982. doi: 10.1016/j.surg.2019.06.025. Epub 2019 Aug 14.

PMID:
31421869
18.

Combination of postoperative C-reactive protein value and computed tomography imaging can predict severe pancreatic fistula after pancreatoduodenectomy.

Uchida Y, Masui T, Nakano K, Yogo A, Yoh T, Nagai K, Anazawa T, Takaori K, Uemoto S.

HPB (Oxford). 2019 Aug 12. pii: S1365-182X(19)30611-2. doi: 10.1016/j.hpb.2019.06.020. [Epub ahead of print]

PMID:
31416787
19.

Right hepatectomy with en-bloc resection of bilateral hepatic arteries for Bismuth type IIIa hilar cholangiocarcinoma: A case report.

Ataka R, Yagi S, Taura K, Uemoto S.

Asian J Surg. 2019 Dec;42(12):1021-1023. doi: 10.1016/j.asjsur.2019.07.018. Epub 2019 Aug 9. No abstract available.

20.

Auxiliary xenotransplantation as an in vivo bioreactor-Development of a transplantable liver graft from a tiny partial liver.

Masano Y, Yagi S, Miyachi Y, Okumura S, Kaido T, Haga H, Kobayashi E, Uemoto S.

Xenotransplantation. 2019 Nov;26(6):e12545. doi: 10.1111/xen.12545. Epub 2019 Aug 9.

PMID:
31400029
21.

Long-term outcome of islet transplantation on insulin-dependent diabetes mellitus: An observational cohort study.

Nakamura T, Fujikura J, Anazawa T, Ito R, Ogura M, Okajima H, Uemoto S, Inagaki N.

J Diabetes Investig. 2019 Aug 7. doi: 10.1111/jdi.13128. [Epub ahead of print]

22.

Different clinical risk scores for prediction of early mortality after liver resection for hepatocellular carcinoma: which is the best?

Badawy A, Seo S, Toda R, Fuji H, Fukumitsu K, Taura K, Kaido T, Uemoto S.

ANZ J Surg. 2019 Oct;89(10):1275-1280. doi: 10.1111/ans.15368. Epub 2019 Aug 6.

PMID:
31389123
23.

Antibiotic pretreatment alleviates liver transplant damage in mice and humans.

Nakamura K, Kageyama S, Ito T, Hirao H, Kadono K, Aziz A, Dery KJ, Everly MJ, Taura K, Uemoto S, Farmer DG, Kaldas FM, Busuttil RW, Kupiec-Weglinski JW.

J Clin Invest. 2019 Jul 22;129(8):3420-3434. doi: 10.1172/JCI127550. eCollection 2019 Jul 22.

24.

Impact of Graft Quality and Fluid Overload on Postoperative Massive Ascites After Living Donor Liver Transplantation.

Iwaki K, Yagi S, Morita S, Hamaguchi Y, Masano Y, Yamamoto G, Ogawa E, Nagai K, Kamo N, Hata K, Taura K, Okajima H, Kaido T, Uemoto S.

Transplant Proc. 2019 Jul - Aug;51(6):1779-1784. doi: 10.1016/j.transproceed.2019.03.038. Epub 2019 Jul 10.

PMID:
31301855
25.

Older Donor Age Is a Risk Factor for Negative Outcomes After Adult Living Donor Liver Transplantation Using Small-for-Size Grafts.

Macshut M, Kaido T, Yao S, Yagi S, Ito T, Kamo N, Nagai K, Sharshar M, Uemoto S.

Liver Transpl. 2019 Oct;25(10):1524-1532. doi: 10.1002/lt.25601. Epub 2019 Aug 14.

PMID:
31298473
26.

Senescence caused by inactivation of the homeodomain transcription factor Pdx1 in adult pancreatic acinar cells in mice.

Horiguchi M, Yoshida M, Hirata K, Furuyama K, Masui T, Uemoto S, Kawaguchi Y.

FEBS Lett. 2019 Aug;593(16):2226-2234. doi: 10.1002/1873-3468.13504. Epub 2019 Jun 30.

PMID:
31240701
27.

Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.

Nakamura N, Hatano E, Iguchi K, Sato M, Kawaguchi H, Ohtsu I, Sakurai T, Aizawa N, Iijima H, Nishiguchi S, Tomono T, Okuda Y, Wada S, Seo S, Taura K, Uemoto S, Ikegawa M.

BMC Cancer. 2019 Jun 25;19(1):621. doi: 10.1186/s12885-019-5825-8.

28.

Up-regulation of FOXO1 and reduced inflammation by β-hydroxybutyric acid are essential diet restriction benefits against liver injury.

Miyauchi T, Uchida Y, Kadono K, Hirao H, Kawasoe J, Watanabe T, Ueda S, Okajima H, Terajima H, Uemoto S.

Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13533-13542. doi: 10.1073/pnas.1820282116. Epub 2019 Jun 13.

29.

Outcomes of liver transplantation for Alagille syndrome after Kasai portoenterostomy: Alagille Syndrome with agenesis of extrahepatic bile ducts at porta hepatis.

Gunadi, Kaneshiro M, Okamoto T, Sonoda M, Ogawa E, Okajima H, Uemoto S.

J Pediatr Surg. 2019 Nov;54(11):2387-2391. doi: 10.1016/j.jpedsurg.2019.04.022. Epub 2019 May 6.

PMID:
31104835
30.

A Minimal Physiologically-Based Pharmacokinetic Model for Tacrolimus in Living-Donor Liver Transplantation: Perspectives Related to Liver Regeneration and the cytochrome P450 3A5 (CYP3A5) Genotype.

Itohara K, Yano I, Tsuzuki T, Uesugi M, Nakagawa S, Yonezawa A, Okajima H, Kaido T, Uemoto S, Matsubara K.

CPT Pharmacometrics Syst Pharmacol. 2019 Aug;8(8):587-595. doi: 10.1002/psp4.12420. Epub 2019 Jun 9.

31.

Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society.

Umeshita K, Eguchi S, Egawa H, Haga H, Kasahara M, Kokudo N, Sakisaka S, Takada Y, Tanaka E, Eguchi H, Uemoto S, Ohdan H.

Hepatol Res. 2019 Sep;49(9):964-980. doi: 10.1111/hepr.13364. Epub 2019 Jul 18.

PMID:
31081572
32.

Surgery for Recurrent Hepatocellular Carcinoma: Achieving Long-term Survival.

Yoh T, Seo S, Taura K, Iguchi K, Ogiso S, Fukumitsu K, Ishii T, Kaido T, Uemoto S.

Ann Surg. 2019 Apr 30. doi: 10.1097/SLA.0000000000003358. [Epub ahead of print]

PMID:
31058698
33.

Bolus Administration of Polyamines Boosts Effects on Hepatic Ischemia-Reperfusion Injury and Regeneration in Rats.

Doi J, Fujimoto Y, Teratani T, Kasahara N, Maeda M, Tsuruyama T, Iida T, Yagi S, Uemoto S.

Eur Surg Res. 2019;60(1-2):63-73. doi: 10.1159/000497434. Epub 2019 May 3.

PMID:
31055575
34.

The Impact of a Nitric Oxide Synthase Inhibitor (L-NAME) on Ischemia⁻Reperfusion Injury of Cholestatic Livers by Pringle Maneuver and Liver Resection after Bile Duct Ligation in Rats.

Iwasaki J, Afify M, Bleilevens C, Klinge U, Weiskirchen R, Steitz J, Vogt M, Yagi S, Nagai K, Uemoto S, Tolba RH.

Int J Mol Sci. 2019 Apr 29;20(9). pii: E2114. doi: 10.3390/ijms20092114.

35.

Novel hybrid three-dimensional artificial liver using human induced pluripotent stem cells and a rat decellularized liver scaffold.

Minami T, Ishii T, Yasuchika K, Fukumitsu K, Ogiso S, Miyauchi Y, Kojima H, Kawai T, Yamaoka R, Oshima Y, Kawamoto H, Kotaka M, Yasuda K, Osafune K, Uemoto S.

Regen Ther. 2019 Mar 30;10:127-133. doi: 10.1016/j.reth.2019.03.002. eCollection 2019 Jun.

36.

Laparoscopic approach for choledochojejunostomy.

Hori T, Aisu Y, Yamamoto M, Yasukawa D, Iida T, Yagi S, Taniguchi K, Uemoto S.

Hepatobiliary Pancreat Dis Int. 2019 Jun;18(3):285-288. doi: 10.1016/j.hbpd.2019.04.004. Epub 2019 Apr 17. Review. No abstract available.

PMID:
31023579
37.

Preoperative Visceral Adiposity and Muscularity Predict Poor Outcomes after Hepatectomy for Hepatocellular Carcinoma.

Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Seo S, Taura K, Okajima H, Uemoto S.

Liver Cancer. 2019 Mar;8(2):92-109. doi: 10.1159/000488779. Epub 2018 Jun 5.

38.

The Efficacy and Limitations of Postoperative Adjuvant Chemotherapy in Patients With Extrahepatic Cholangiocarcinoma.

Morino K, Seo S, Yoh T, Nishino H, Yamanaka K, Fukumitsu K, Ishii T, Taura K, Okajima H, Kaido T, Uemoto S.

Anticancer Res. 2019 Apr;39(4):2155-2161. doi: 10.21873/anticanres.13329.

PMID:
30952762
39.

Laparoscopic Left Lateral Sectionectomy Using the Extrahepatic Glissonean Approach: A Secure Option for Achieving a Negative Margin for Lesions with Ductal Extension.

Ogiso S, Seo S, Okumura S, Ishii T, Fukumitsu K, Ito T, Masui T, Taura K, Kaido T, Uemoto S.

Ann Surg Oncol. 2019 Jun;26(6):1858. doi: 10.1245/s10434-019-07298-8. Epub 2019 Mar 18.

PMID:
30887372
40.

Significance of preoperative sarcopenia to liver surgery.

Kaido T, Hamaguchi Y, Uemoto S.

Hepatobiliary Surg Nutr. 2019 Feb;8(1):59-62. doi: 10.21037/hbsn.2018.11.05. No abstract available.

41.

Predictive value of the Ki67 index for lymph node metastasis of small non-functioning pancreatic neuroendocrine neoplasms.

Masui T, Sato A, Nakano K, Uchida Y, Yogo A, Anazawa T, Nagai K, Kawaguchi Y, Takaori K, Uemoto S.

Surg Today. 2019 Jul;49(7):593-600. doi: 10.1007/s00595-019-01779-9. Epub 2019 Mar 5.

PMID:
30838442
42.

Impact of imbalanced graft-to-spleen volume ratio on outcomes following living donor liver transplantation in an era when simultaneous splenectomy is not typically indicated.

Yao S, Kaido T, Yagi S, Uozumi R, Iwamura S, Miyachi Y, Shirai H, Kamo N, Taura K, Okajima H, Uemoto S.

Am J Transplant. 2019 Oct;19(10):2783-2794. doi: 10.1111/ajt.15337. Epub 2019 Mar 26.

PMID:
30830721
43.

Clinical Practice of Postoperative Adjuvant Chemotherapy in Patients with Colorectal Liver Metastases: Impact of the Completion for Six Months.

Nishino H, Hatano E, Okuno M, Toda R, Seo S, Taura K, Horimatsu T, Kanai M, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S.

Am Surg. 2019 Feb 1;85(2):e111-e114. No abstract available.

PMID:
30819321
44.

Efficacy and safety of glecaprevir and pibrentasvir treatment for 8 or 12 weeks in patients with recurrent hepatitis C after liver transplantation: a Japanese multicenter experience.

Ueda Y, Kobayashi T, Ikegami T, Miuma S, Mizuno S, Akamatsu N, Takaki A, Ishigami M, Takatsuki M, Sugawara Y, Maehara Y, Uemoto S, Seno H.

J Gastroenterol. 2019 Jul;54(7):660-666. doi: 10.1007/s00535-019-01561-1. Epub 2019 Feb 26.

PMID:
30806783
45.

Comprehensive analysis of genetic aberrations linked to tumorigenesis in regenerative nodules of liver cirrhosis.

Kim SK, Takeda H, Takai A, Matsumoto T, Kakiuchi N, Yokoyama A, Yoshida K, Kaido T, Uemoto S, Minamiguchi S, Haga H, Shiraishi Y, Miyano S, Seno H, Ogawa S, Marusawa H.

J Gastroenterol. 2019 Jul;54(7):628-640. doi: 10.1007/s00535-019-01555-z. Epub 2019 Feb 12.

PMID:
30756187
46.

Reply - Letter to the Editor - Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.

Kaido T, Kamo N, Uemoto S.

Clin Nutr. 2019 Apr;38(2):967. doi: 10.1016/j.clnu.2019.01.024. Epub 2019 Feb 1. No abstract available.

PMID:
30739810
47.

Exocrine tissue-driven TFF2 prevents apoptotic cell death of endocrine lineage during pancreas organogenesis.

Hirata K, Kodama S, Nakano Y, Minaki-Nakagawa Y, Aoyama Y, Sakikubo M, Goto T, Yoshida M, Masui T, Yamamoto T, Uemoto S, Kawaguchi Y.

Sci Rep. 2019 Feb 7;9(1):1636. doi: 10.1038/s41598-018-38062-9.

48.

Clinical and experimental studies of intraperitoneal lipolysis and the development of clinically relevant pancreatic fistula after pancreatic surgery.

Uchida Y, Masui T, Nakano K, Yogo A, Sato A, Nagai K, Anazawa T, Takaori K, Tabata Y, Uemoto S.

Br J Surg. 2019 Apr;106(5):616-625. doi: 10.1002/bjs.11075. Epub 2019 Feb 6.

PMID:
30725479
49.

Early post-operative intravenous tacrolimus in pediatric liver transplant recipients is not superior to oral tacrolimus.

Sabra TA, Okajima H, Yoshizawa A, Ogawa E, Okamoto S, Osman MA, Saad-Eldin Y, Uemoto S.

Pediatr Transplant. 2019 May;23(3):e13368. doi: 10.1111/petr.13368. Epub 2019 Feb 4.

PMID:
30719833
50.

Risk-benefit point of the Model for End-stage Liver Disease score in patients waiting for deceased-donor liver transplantation: A single-center experience.

Iwamura S, Kaido T, Morita S, Miyachi Y, Yao S, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, Yagi S, Uemoto S.

Hepatol Res. 2019 Jun;49(6):687-694. doi: 10.1111/hepr.13320. Epub 2019 Mar 1.

PMID:
30698359

Supplemental Content

Loading ...
Support Center